Pfizer Inc yesterday reported second-quarter earnings slightly ahead of forecasts as the largest US drugmaker lines up a business split that could lead to the spin-off of its generics division.
The company reaffirmed its financial outlook for the year.
For the second quarter, Pfizer’s adjusted income fell 10 percent to US$4 billion, or US$0.56 a share, from US$4.45 billion, or US$0.59 a share, a year earlier. Revenue fell 7 percent to US$12.97 billion.
Analysts, on average, were expecting second-quarter income of US$0.55 a share, on revenue of US$13.01 billion, according to Thomson Reuters I/B/E/S.
Pfizer, whose CEO Ian Read has been reviewing the group’s structure after divesting its nutrition and animal health businesses, said on Monday that it planned to separate its commercial operations into two units for branded products and a third for generics.
Pfizer’s new model would help revitalize its innovation-based core drugs business, while enhancing the value of consumer and off-patent established brands, and maximizing the use of capital, Read said..
Pfizer’s generics business, which represents 17 percent of total sales, has far lower profit margins than its patent-protected drugs. Many analysts have urged Pfizer to spin off its generics business so it can focus on its core branded pharmaceuticals business, although any spin-off of a division is unlikely before 2016.
Within the core drugs division, revenues from cancer medicines increased by 28 percent in the second quarter.
Read also said he expected business in emerging markets to accelerate in the second half of the year, led by China.
To many, Tatu City on the outskirts of Nairobi looks like a success. The first city entirely built by a private company to be operational in east Africa, with about 25,000 people living and working there, it accounts for about two-thirds of all foreign investment in Kenya. Its low-tax status has attracted more than 100 businesses including Heineken, coffee brand Dormans, and the biggest call-center and cold-chain transport firms in the region. However, to some local politicians, Tatu City has looked more like a target for extortion. A parade of governors have demanded land worth millions of dollars in exchange
An Indonesian animated movie is smashing regional box office records and could be set for wider success as it prepares to open beyond the Southeast Asian archipelago’s silver screens. Jumbo — a film based on the adventures of main character, Don, a large orphaned Indonesian boy facing bullying at school — last month became the highest-grossing Southeast Asian animated film, raking in more than US$8 million. Released at the end of March to coincide with the Eid holidays after the Islamic fasting month of Ramadan, the movie has hit 8 million ticket sales, the third-highest in Indonesian cinema history, Film
Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) revenue jumped 48 percent last month, underscoring how electronics firms scrambled to acquire essential components before global tariffs took effect. The main chipmaker for Apple Inc and Nvidia Corp reported monthly sales of NT$349.6 billion (US$11.6 billion). That compares with the average analysts’ estimate for a 38 percent rise in second-quarter revenue. US President Donald Trump’s trade war is prompting economists to retool GDP forecasts worldwide, casting doubt over the outlook for everything from iPhone demand to computing and datacenter construction. However, TSMC — a barometer for global tech spending given its central role in the
Alchip Technologies Ltd (世芯), an application-specific integrated circuit (ASIC) designer specializing in server chips, expects revenue to decline this year due to sagging demand for 5-nanometer artificial intelligence (AI) chips from a North America-based major customer, a company executive said yesterday. That would be the first contraction in revenue for Alchip as it has been enjoying strong revenue growth over the past few years, benefiting from cloud-service providers’ moves to reduce dependence on Nvidia Corp’s expensive AI chips by building their own AI accelerator by outsourcing chip design. The 5-nanometer chip was supposed to be a new growth engine as the lifecycle